| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 129, 242-256, Copyright © 1987 by American Society for Investigative Pathology
REGULAR ARTICLES |
HK Muller-Hermelink, GE Sale, B Borisch and R Storb
Pathological Institute, University of Wurzburg, West Germany.
A major hypothesis to explain the immunodeficiency associated with bone marrow transplantation states that thymic epithelial damage due to graft-versus-host disease (GVHD) abrogates or delays the recovery of normal immunologic function. This study evaluated the thymus glands of 36 human bone marrow transplant recipients dying between 4 and 1742 days after transplant using histology, histochemistry, and immunohistology. The observations lead to a model of thymic damage by irradiation, chemotherapy, and GVHD in which early injury by all three of these agents results in profound thymic atrophy followed by long- delayed restitution. Patients undergoing total body irradiation showed more severe damage to thymic cortical and medullary epithelium than did patients undergoing chemotherapy alone as preparation for transplantation. Patients with GVHD showed additional damage in the form of individual thymic epithelial cell death and showed HLA-DR surface protein expression on thymic epithelium during GVHD. Longer- term survivors showed a profoundly delayed restitution of normal thymic epithelium and delayed evidence of restored lymphopoiesis. A few patients dying late after transplant showed evidence of reconstitution of normal thymic structure or nodules of lymphopoiesis in focal areas of epithelial-cell reconstitution. Evidence of such lymphopoiesis was seen at times ranging between 90 and 1742 days after grafting. The data are consistent with a model of long-standing thymic damage caused by GVHD which is reversible after the development of tolerance.
This article has been cited by other articles:
![]() |
R. W. Hick, A. L. Gruver, M. S. Ventevogel, B. F. Haynes, and G. D. Sempowski Leptin Selectively Augments Thymopoiesis in Leptin Deficiency and Lipopolysaccharide-Induced Thymic Atrophy J. Immunol., July 1, 2006; 177(1): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Sinha, T. J. Fry, D. H. Fowler, G. Miller, and C. L. Mackall Interleukin 7 worsens graft-versus-host disease Blood, September 18, 2002; 100(7): 2642 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Storek, A. Joseph, G. Espino, M. A. Dawson, D. C. Douek, K. M. Sullivan, M. E. D. Flowers, P. Martin, G. Mathioudakis, R. A. Nash, et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation Blood, December 15, 2001; 98(13): 3505 - 3512. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Storek, M. A. Dawson, B. Storer, T. Stevens-Ayers, D. G. Maloney, K. A. Marr, R. P. Witherspoon, W. Bensinger, M. E. D. Flowers, P. Martin, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood, June 1, 2001; 97(11): 3380 - 3389. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Godthelp, M. J. D. van Tol, J. M. Vossen, and P. J. van den Elsen Longitudinal analysis of T cells responding to tetanus toxoid in healthy subjects as well as in pediatric patients after bone marrow transplantation: the identification of identical TCR-CDR3 regions in time suggests long-term stability of at least part of the antigen-specific TCR repertoire Int. Immunol., April 1, 2001; 13(4): 507 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Godthelp, M. J.D. van Tol, J. M. Vossen, and P. J. van den Elsen T-Cell Immune Reconstitution in Pediatric Leukemia Patients After Allogeneic Bone Marrow Transplantation With T-Cell-Depleted or Unmanipulated Grafts: Evaluation of Overall and Antigen-Specific T-Cell Repertoires Blood, December 15, 1999; 94(12): 4358 - 4369. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Hebib, O. Deas, M. Rouleau, A. Durrbach, B. Charpentier, F. Beaujean, J.-P. Vernant, and A. Senik Peripheral Blood T Cells Generated After Allogeneic Bone Marrow Transplantation: Lower Levels of Bcl-2 Protein and Enhanced Sensitivity to Spontaneous and CD95-Mediated Apoptosis In Vitro. Abrogation of the Apoptotic Phenotype Coincides With the Recovery of Normal Naive/Primed T-Cell Profiles Blood, September 1, 1999; 94(5): 1803 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brochu, B. Rioux-Masse, J. Roy, D.-C. Roy, and C. Perreault Massive Activation-Induced Cell Death of Alloreactive T Cells With Apoptosis of Bystander Postthymic T Cells Prevents Immune Reconstitution in Mice With Graft-Versus-Host Disease Blood, July 15, 1999; 94(2): 390 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Godthelp, M. C.J.A. van Eggermond, A. Peijnenburg, I. Tezcan, S. van Lierde, M. J.D. van Tol, J. M. Vossen, and P. J. van den Elsen Incomplete T-Cell Immune Reconstitution in Two Major Histocompatibility Complex Class II-Deficiency/Bare Lymphocyte Syndrome Patients After HLA-Identical Sibling Bone Marrow Transplantation Blood, July 1, 1999; 94(1): 348 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dumont-Girard, E. Roux, R. A. van Lier, G. Hale, C. Helg, B. Chapuis, M. Starobinski, and E. Roosnek Reconstitution of the T-Cell Compartment After Bone Marrow Transplantation: Restoration of the Repertoire by Thymic Emigrants Blood, December 1, 1998; 92(11): 4464 - 4471. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Guillaume, D. B. Rubinstein, and M. Symann Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation Blood, September 1, 1998; 92(5): 1471 - 1490. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |